MedPath

Vinegar Co-ingestion in Type 2 Diabetes

Not Applicable
Completed
Conditions
Type 2 Diabetes Mellitus
Interventions
Dietary Supplement: vinegar co-ingestion
Dietary Supplement: placebo co-ingestion
Registration Number
NCT01279317
Lead Sponsor
Maastricht University Medical Center
Brief Summary

The main objective of this study is to assess the acute effect of co-ingested vinegar on postprandial plasma glucose levels in type 2 diabetes patients.

Detailed Description

Plasma glucose and insulin concentrations are assessed over the 2 hr period following ingestion of carbohydrate-rich beverage with or without added vinegar.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
12
Inclusion Criteria
  • male type 2 diabetes
  • overweight or obese
  • 40-70 yrs
Exclusion Criteria
  • incident cardiovascular events during last year
  • peptic ulcer, duodenal ulcer, oesophageal reflux
  • antacids, H2 receptor blocker, proton pump inhibitors, NSAIDS, prokinetic agents

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
vinegar co-ingestionvinegar co-ingestion25 ml vinegar is added to glucose containing beverage
Placebo co-ingestionplacebo co-ingestion25 ml vinegar is substituted by 25 ml water
Primary Outcome Measures
NameTimeMethod
Postprandial Glycemic Incremental Area Under the Curve2 hr

area under the plasma glucose concentration curve, above the baseline plasma glucose, measured over 2 hr following ingestion of a the intervention beverages

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Maastricht University Medical Centre

🇳🇱

Maastricht, Limburg, Netherlands

© Copyright 2025. All Rights Reserved by MedPath